Skip to content

Circles

S

Spyre Therapeutics, Inc.

SYRE· Nasdaq

S

SYRESpyre Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.·Earnings record

Q3 2015

Source filing unavailable

Previous · Q2 2015 Next · Q4 2015

Q3 2015 · —

Revenue—

Net Income

-$3.41M

no prior Q3 2014 on file

EPS Diluted

-$5.57

no prior Q3 2014 on file

Operating Income-$3,417,000—

Operating Cash Flowderived-$3,811,000—

Free Cash Flowderived

Same quarter

no prior Q3 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’15 Q2 ’15Q3 ’15Q4 ’15 Q1 ’16 Q2 ’16 Q3 ’16 Q4 ’16 Q1 ’17…

Spyre Therapeutics, Inc. · CIK 1636282 · Engraved from SEC EDGAR

-$3,945,000

—

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy